CRAMP (20-35)

General Information


DRACP ID  DRACP01921

Peptide Name   CRAMP (20-35)

Sequence  KKIGQKIKNFFQKL

Sequence Length  14

UniProt ID  P51437 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Hep-G2 Hepatoblastoma Blastoma EC50>50µM MTT assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01921

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C82H138N22O18

Absent amino acids  ACDEHMPRSTVWY

Common amino acids  K

Mass  195220

Pl  11.4

Basic residues  5

Acidic residues  0

Hydrophobic residues  5

Net charge  5

Boman Index  -2381

Hydrophobicity  -85.71

Aliphatic Index  83.57

Half Life 
  Mammalian: 100 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30176261

Title  Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33

Doi 10.1016/j.peptides.2018.08.013

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_12498

DRACP is developed by Dr.Zheng's team.